Incannex Healthcare IXHL 深 滬
已收盤 03-27 16:00:00 美东时间
3.24
-0.170
-4.99%
華盛通- 最 高3.68
- 今 開3.48
- 成交量 69.03万股
- 最 低 3.21
- 昨 收 3.41
- 總市值 3869.96万
- 52周最高 49.80
- 市盈率 靜 --
- 換手率 5.78%
- 52周最低 2.40
- 委 比 -13.12%
- 總股本 1194.43万
- 歷史最高 10800.00
- 量 比 1.19
- 振 幅 13.78%
- 歷史最低 2.40
- 每 手 1
- 風險率 6.21%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Incannex Reactivates Share Buyback, Signaling Valuation Confidence
The latest update is out from Incannex Healthcare Limited Sponsored ADR ( ($IXH...
03-27 21:17
BRIEF-Incannex Reactivates Share Repurchase Program, Underscoring Confidence In Valuation And Strategic Position
BRIEF-Incannex Reactivates Share Repurchase Program, Underscoring Confidence In Valuation And Strategic Position Incannex Healthcare Inc IXHL.O : INCANNEX REACTIVATES SHARE REPURCHASE PROGRAM, UNDERSCORING CONFIDENCE IN VALUATION AND STRATEGIC POSITION Source text: ID:nGNX8G1VpZ Further company cove
03-27 20:05
Incannex Healthcare Reactivates Previously Approved Buyback Plan
Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, today announced that it has reactivated its previously approved share repurchase program,
03-27 20:03
Incannex Healthcare Announces Partnership with the AASM Foundation in Support of Sleep Apnea Research
Incannex Healthcare joins the AASM Foundation's Corporate Recognition Program and sponsors a research grant for junior investigators focused on sleep apnea. The company advances IHL-42X, an oral treatment for obstructive sleep apnea, with recent milestones including positive Phase 2 results, FDA Fast Track designation, and the onset of the DReAMzz Phase 2 study. The partnership supports innovation and the next generation of sleep medicine researc...
03-25 12:00
Incannex Healthcare Holds ~$75M In Cash With No Debt
Incannex Healthcare Inc. (NASDAQ:IXHL), a clinical-stage biopharmaceutical company developing combination therapies for high-impact indications, today reported that it holds approximately $75 million in cash with no
03-18 20:04
Incannex Regains Nasdaq Compliance, Strengthening Pipeline Progress
An announcement from Incannex Healthcare Limited Sponsored ADR ( ($IXHL) ) is n...
03-17 20:39
Incannex Regains Compliance with Nasdaq Minimum Bid Price Requirement
Incannex Healthcare Inc. announced it has regained compliance with Nasdaq's minimum bid price requirement after its stock closed at $1 or higher for 11 consecutive days, ensuring continued listing on Nasdaq. The company has $75M in cash, no debt, and a strong pipeline of clinical programs, including IHL-42X for sleep apnea and PSX-001 for anxiety. "This achievement reinforces our listing and strengthens our position to advance our programs," said...
03-17 12:00
Incannex Highlights Enhanced Phase 2 Study and Updates
The latest update is out from Incannex Healthcare Limited Sponsored ADR ( ($IXH...
03-12 20:42
Incannex Healthcare Announces $10 Million Direct Offering
Incannex Healthcare Limited Sponsored ADR ( ($IXHL) ) has issued an announcemen...
03-12 20:40
Incannex Healthcare Announces Enhanced Clinical Development Strategy For IHL-42X To Treat Obstructive Sleep Apnea
Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, today announced an enhanced clinical development strategy for IHL-42X, its lead oral drug
03-12 20:19
